Patients with type 1 diabetes are at elevated risk of developing new hypertension, chronic kidney disease and diabetic ketoacidosis after COVID-19: Up to 40 months' follow-up.
Shiv Mehrotra-VarmaJustin Y LuMontek Singh BoparaiSonya HenryStephen H WangTimothy Q DuongPublished in: Diabetes, obesity & metabolism (2024)
T1D patients with COVID-19 are at higher risk of developing new HTN, CKD and DKA compared to T1D patients without COVID-19.